603 related articles for article (PubMed ID: 24330412)
1. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
Andrae DA; Patrick DL; Drossman DA; Covington PS
Health Qual Life Outcomes; 2013 Dec; 11():208. PubMed ID: 24330412
[TBL] [Abstract][Full Text] [Related]
2. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
Andrae DA; Covington PS; Patrick DL
Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
[TBL] [Abstract][Full Text] [Related]
3. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
Abel JL; Carson RT; Andrae DA
Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
[TBL] [Abstract][Full Text] [Related]
4. Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation.
Lee EH; Kwon O; Hahm KB; Kim W; Kim JI; Cheung DY; Kim YJ; Kim JH; Park JJ; Joo MK
Health Qual Life Outcomes; 2016 Feb; 14():22. PubMed ID: 26882900
[TBL] [Abstract][Full Text] [Related]
5. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
6. Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) as a measure of bowel-related quality of life in spinal cord injury.
Abedi A; Kohli P; Montero S; Morales L; Ha N; Abedi A; La Riva A; Ginsberg D; Kreydin E
Neurourol Urodyn; 2023 Aug; 42(6):1362-1373. PubMed ID: 37166006
[TBL] [Abstract][Full Text] [Related]
7. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide.
Brenner DM; Sayuk GS; Abel JL; Burslem K
J Manag Care Spec Pharm; 2021 Apr; 27(4):469-477. PubMed ID: 33769858
[No Abstract] [Full Text] [Related]
8. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea.
Zhu L; Huang D; Shi L; Liang L; Xu T; Chang M; Chen W; Wu D; Zhang F; Fang X
Health Qual Life Outcomes; 2015 Apr; 13():49. PubMed ID: 25925746
[TBL] [Abstract][Full Text] [Related]
9. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome.
Jamali R; Biglari M
Acta Med Iran; 2015 Nov; 53(11):717-24. PubMed ID: 26786994
[TBL] [Abstract][Full Text] [Related]
10. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.
Huang WW; Zhou FS; Bushnell DM; Diakite C; Yang XH
Qual Life Res; 2007 Aug; 16(6):991-6. PubMed ID: 17440830
[TBL] [Abstract][Full Text] [Related]
11. Performance of the EQ-5D in patients with irritable bowel syndrome.
Bushnell DM; Martin ML; Ricci JF; Bracco A
Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
[TBL] [Abstract][Full Text] [Related]
12. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
Ljótsson B; Jones M; Talley NJ; Kjellström L; Agréus L; Andreasson A
United European Gastroenterol J; 2020 Apr; 8(3):284-292. PubMed ID: 32213021
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
14. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome.
Krarup AL; Peterson E; Ringström G; Törnblom H; Hjortswang H; Simrén M
J Clin Gastroenterol; 2015 Aug; 49(7):565-70. PubMed ID: 25216385
[TBL] [Abstract][Full Text] [Related]
15. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
[TBL] [Abstract][Full Text] [Related]
17. Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina.
Schmulson M; Ortiz O; Mejia-Arangure JM; Hu YB; Morris C; Arcila D; Gutierrez-Reyes G; Bangdiwala S; Drossman DA
Dig Dis Sci; 2007 Nov; 52(11):2950-5. PubMed ID: 17415635
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
[TBL] [Abstract][Full Text] [Related]
19. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
[TBL] [Abstract][Full Text] [Related]
20. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
Olden KW; Chey WD; Shringarpure R; Paul Nicandro J; Chuang E; Earnest DL
Curr Med Res Opin; 2019 Mar; 35(3):461-472. PubMed ID: 30293448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
